OBJECTIVES: We examined sexually transmitted infection (STI), HIV, and hepatitis virus prevalence and risk behaviors among truck drivers. METHODS: We asked participants about their risk behaviors, and we screened them for STIs, HIV, and hepatitis infections. We used logistic regression to identify factors associated with outcomes. RESULTS: Of the 652 enrolled participants, 21% reported sex with sex workers or casual partners in the prior year. Driving solo (odds ratio [OR] = 15.04; 95% confidence interval [CI] = 1.92, 117.53; P = .01), history of injection drug use (IDU; OR = 2.69; 95% CI = 1.19, 6.12; P = .02), and history of an STI (OR = 2.47; 95% CI = 1.19, 5.09; P = .01) were independently associated with high-risk sexual behaviors. Fourteen percent of participants reported drug use in the previous year, and 11% reported having ever injected drugs. Participants tested positive as follows: 54 for HCV antibodies (8.5%), 66 for hepatitis B anticore (anti-HBc) antibodies (10.4%), 8 for chlamydia (1.3%), 1 for gonorrhea (0.2%), 1 for syphilis (0.2%), and 1 for HIV (0.2%). History of injecting drugs (OR = 26.91; 95% CI = 11.61, 62.39; P < .01) and history of anti-HBc antibodies (OR = 7.89; 95% CI = 3.16, 19.68; P < .01) were associated with HCV infection. CONCLUSIONS: Our results suggest a need for hepatitis C screening and STI risk-reduction interventions in this population.
OBJECTIVES: We examined sexually transmitted infection (STI), HIV, and hepatitis virus prevalence and risk behaviors among truck drivers. METHODS: We asked participants about their risk behaviors, and we screened them for STIs, HIV, and hepatitis infections. We used logistic regression to identify factors associated with outcomes. RESULTS: Of the 652 enrolled participants, 21% reported sex with sex workers or casual partners in the prior year. Driving solo (odds ratio [OR] = 15.04; 95% confidence interval [CI] = 1.92, 117.53; P = .01), history of injection drug use (IDU; OR = 2.69; 95% CI = 1.19, 6.12; P = .02), and history of an STI (OR = 2.47; 95% CI = 1.19, 5.09; P = .01) were independently associated with high-risk sexual behaviors. Fourteen percent of participants reported drug use in the previous year, and 11% reported having ever injected drugs. Participants tested positive as follows: 54 for HCV antibodies (8.5%), 66 for hepatitis B anticore (anti-HBc) antibodies (10.4%), 8 for chlamydia (1.3%), 1 for gonorrhea (0.2%), 1 for syphilis (0.2%), and 1 for HIV (0.2%). History of injecting drugs (OR = 26.91; 95% CI = 11.61, 62.39; P < .01) and history of anti-HBc antibodies (OR = 7.89; 95% CI = 3.16, 19.68; P < .01) were associated with HCV infection. CONCLUSIONS: Our results suggest a need for hepatitis C screening and STI risk-reduction interventions in this population.
Authors: Beth P Bell; M Michele Manos; Atif Zaman; Norah Terrault; Ann Thomas; Victor J Navarro; Kathy B Dhotre; Rosemary C Murphy; Grace R Van Ness; Nicole Stabach; Marie E Robert; William A Bower; Stephanie R Bialek; Andre N Sofair Journal: Am J Gastroenterol Date: 2008-07-31 Impact factor: 10.864
Authors: Laura H Bachmann; Bronwen Lichtenstein; Janet S St Lawrence; Margaret Murray; Gregory B Russell; Edward W Hook Journal: J Occup Environ Med Date: 2018-07 Impact factor: 2.162
Authors: Donna Hubbard McCree; Shannon Cosgrove; Dale Stratford; Sarah Valway; Nick Keller; Jaime Vega-Hernandez; Steven A Jenison Journal: Public Health Rep Date: 2010 Jan-Feb Impact factor: 2.792
Authors: Sunil S Solomon; Sandra Wagner-Cardoso; Laura Smeaton; Leonard A Sowah; Chanelle Wimbish; Gregory Robbins; Irena Brates; Christine Scello; Annie Son; Anchalee Avihingsanon; Benjamin Linas; Donald Anthony; Estevão Portela Nunes; Dimas A Kliemann; Khuanchai Supparatpinyo; Cissy Kityo; Pablo Tebas; Jaclyn Ann Bennet; Jorge Santana-Bagur; Constance A Benson; Marije Van Schalkwyk; Nelson Cheinquer; Susanna Naggie; David Wyles; Mark Sulkowski Journal: Lancet Gastroenterol Hepatol Date: 2022-01-10
Authors: Nara R Freitas; Sheila A Teles; Marcos A Matos; Carmen Lr Lopes; Nádia Rs Reis; Márcia P Espírito-Santo; Elisabeth Lampe; Regina Mb Martins Journal: Virol J Date: 2010-08-27 Impact factor: 4.099
Authors: Samanta Tresha Lalla-Edward; Sydney Ncube; Paul Matthew; Catherine A Hankins; W D Francois Venter; Gabriela B Gomez Journal: BMC Health Serv Res Date: 2017-09-13 Impact factor: 2.655